S 3537
116th Congress
Senate
Health
Asia
Business expenses
China
Drug safety, medical device, and laboratory regulation
Government information and archives
Health care costs and insurance
Health programs administration and funding
Health technology, devices, supplies
Income tax deductions
Manufacturing
Military medicine
Military procurement, research, weapons development
Prescription drugs
Public contracts and procurement
Trade restrictions
Veterans' medical care
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 19, 2020
Read twice and referred to the Committee on Finance.
Mar 19, 2020
Introduced in Senate
Plain-English summary
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1